Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




CE Mark Awarded to First Commercial Head And Neck Deep Learning Solution

By HospiMedica International staff writers
Posted on 29 Nov 2017
The world's first commercial head and neck deep learning medical imaging solution from Aidoc (Tel-Aviv, Israel), an AI startup utilizing deep learning to augment radiologists' workflow and highlight anomalous cases, has received CE (Conformité Européenne) marking, allowing for its widespread commercialization in Europe.

Aidoc utilizes advanced innovations in deep learning and artificial intelligence to augment radiology, with the goal of cutting healthcare costs without sacrificing quality results. More...
The company’s solution analyzes all relevant imaging and clinical data, providing radiologists with highly accurate detection, streamlining workflow and breaking through bottlenecks by allowing them to focus on the diagnosis.

Aidoc's solution augments radiologists' workflow through its ability to comprehensively detect abnormalities in imaging of the head and neck, an anatomical area responsible for a major portion of medical images. Radiologists can now perform smart optimization of their worklist by prioritizing cases based on AI medical image analysis in conjunction with other clinically available data. Aidoc's solution is agnostic to radiologists' incumbent software, integrating seamlessly and providing immediate results.

"The amount of medical imaging - especially CT and MR scans - is increasing dramatically, but the number of radiologists has plateaued, creating unsustainable bottlenecks and making the radiologist's already complex work even more challenging," said Aidoc CEO Elad Walach. "Our technology can have a monumental impact augmenting the radiology workflow, aimed at more cost-effective treatment for medical centers and practices, and the healthcare system as a whole. With the CE mark, we have a unique opportunity to update outdated technology for the benefit of hundreds of millions of Europeans."

Related Links:
Aidoc


Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Silver Member
X-Ray QA Device
Accu-Gold+ Touch Pro
Floor‑Mounted Digital X‑Ray System
MasteRad MX30+
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: A smartphone application displays a glucose concentration that was measured using the new sensor (Photo courtesy of Chuchu Chen and Yonghao Fu)

Wearable Device for Diabetics Could Replace Continuous Glucose Monitoring Systems

Monitoring blood glucose is essential for people with diabetes to prevent complications and maintain long-term health. Current continuous glucose monitoring systems require needles inserted under the skin,... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.